Insider Transaction Report for Aligos Therapeutics, Inc.

This filing details a stock option grant to Margarita Chavez, a director at Aligos Therapeutics, Inc. (ALGS). The option, for 5,860 shares of Common Stock, was granted on June 25, 2026, with an exercise price of $5.50 per share and an expiration date of June 25, 2036. The shares will vest on the earlier of the first anniversary of the grant date or immediately prior to the 2027 annual meeting, contingent upon continuous service. The transaction is reported on Form 4, with a post-transaction ownership of 5,860 shares for Ms. Chavez. The filing was signed on June 29, 2026.